title: [THE USE OF 20% LIPOFUNDIN INFUSIONS AT THE APPEARANCE OF TOXIC PROPERTIES OF ROPIVACAINE 2 MG/ML IN CHILD 1.5 MONTHS AT THE POSTOPERATIVE PERIOD WITH EPIDURAL ANALGESIA].
abstract: Introduction of local anesthetic proved application of epidural (EP) as an effective and safe way of an analgesia in intra- and the post-operational period and now it is widely applied at children of all age groups (1). However there is a number of contraindications for application of this type of an analgesia. At children till 6 months lower dosages of a ropivacain of 2 mg/kg are applied, considering their age features. At the phenomena of system toxicity infusion of 20% lipofundin is applied. The child has an age 1.5 months, weight 5230 g, with the diagnosis a cystous dysplasia of both kidneys, a megaureter at the left and on the right, lack offunction of the left kidney operation a laparoscopic nefrureterektomia is executed at the left. In the postoperative period at application of EP of an analgesia ofropivacain 2 mg/ml by a drop way introduction in a standard dosage of 0.2 mg/kg of body weight an hour the repeating episodes of convulsions which were regarded as manifestation of toxic properties of local anesthetic were noted. Infusion of 20% lipofundin of 15 ml (2.8 ml/kg of body weight) within 30 minutes with a positive effect was applied. EP an analgesia was recoloured.
authors.forename: S Yu
authors.initials: SY
authors.lastname: Sichkar
authors.forename: I I
authors.initials: II
authors.lastname: Afukov
authors.forename: O V
authors.initials: OV
authors.lastname: Koshko
authors.forename: N V
authors.initials: NV
authors.lastname: Yeliseeva
mesh_terms: D000577:Amides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D015360:Analgesia, Epidural / Q000379:methods*; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous; D008297:Male; D010149:Postoperative Pain / Q000517:prevention & control*; D010743:Phospholipids / Q000008:administration & dosage / Q000627:therapeutic use*; D000077212:Ropivacaine; D013012:Sorbitol / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014564:Urogenital Abnormalities / Q000601:surgery*
chemical_list: D000577:Amides; D000779:Anesthetics, Local; D004338:Drug Combinations; D010743:Phospholipids; C008288:Lipofundin; D013012:Sorbitol; D000077212:Ropivacaine